Stelios Papadopoulos
Affiliations
- Director at Exelixis Inc. (EXEL), 2025-05-30
- at Regulus Therapeutics Inc. (RGLS), 2025-04-30
- at Ovid Therapeutics Inc. (OVID), 2025-03-04
- Director at Biogen Inc. (BIIB), 2022-06-17
- Large Shareholder, Director at Eucrates Biomedical Acquisition Corp. (EUCR), 2020-11-27
- Director at Bg Medicine Inc. (BGMD), 2015-11-20
- Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| RGLS | $1.08 | 370,370 | $399,999.60 | 1,189,872 | 2019-05-07 | Filing |
| RGLS | $1.09 | 50,000 | $54,570.00 | 835,073 | 2018-12-28 | Filing |
| RGLS | $1.04 | 26,401 | $27,459.68 | 785,073 | 2018-12-27 | Filing |
| RGLS | $0.95 | 90,000 | $85,878.00 | 758,672 | 2018-12-26 | Filing |
| RGLS | $1.38 | 300,000 | $415,470.00 | 668,672 | 2018-11-16 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| EXEL | $44.35 | 15,874 | $704,011.90 | 1,279,416 | 2025-05-15 | Filing |
| EXEL | $44.35 | 20,634 | $915,117.90 | 1,279,416 | 2025-05-15 | Filing |
| EXEL | $21.00 | 11,437 | $240,177.00 | 1,260,578 | 2024-05-20 | Filing |
| EXEL | $19.56 | 84,515 | $1,653,113.40 | 1,220,036 | 2022-02-22 | Filing |
| EXEL | $25.01 | 5,473 | $136,879.73 | 1,288,127 | 2021-05-11 | Filing |